The phosphorylation status of merlin in sporadic vestibular Schwannomas

Zhaoyan Wang1, Yanjun Lu, Juanjuan Tang

  • 1Department of Otolaryngology-Head & Neck Surgery, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, 1665 Kongjiang Road, Shanghai, 200092, China.

Insights

Merlin loss is common in sporadic vestibular Schwannomas, with phosphorylated merlin correlating to increased tumor size and Ras/Rac/PAK signaling, suggesting its role in tumorigenesis.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Cell signaling

Background:

  • Schwannoma development mechanisms remain unclear.
  • Merlin protein functions as a tumor suppressor by inhibiting Ras-mediated signaling.
  • Sporadic vestibular Schwannomas are common tumors affecting the nervous system.

Purpose of the Study:

  • To investigate the role of merlin in sporadic vestibular Schwannoma development.
  • To analyze the correlation between merlin status and clinical behavior.
  • To elucidate the signaling pathways involved in Schwannoma pathogenesis.

Main Methods:

  • Analysis of clinical and biological data from seven sporadic vestibular Schwannomas.
  • Assessment of merlin expression and phosphorylation status.
  • Evaluation of CDKs/cyclins and p27 levels.
  • Investigation of Ras/Rac/PAK signaling pathways.

Main Results:

  • Merlin loss (expression or phosphorylation) was frequently observed.
  • Loss of functional merlin correlated with heightened CDKs/cyclins and reduced p27.
  • Phosphorylated merlin was associated with increased Ras/Rac/PAK signaling.
  • Increased merlin phosphorylation correlated with larger tumor size.

Conclusions:

  • Phosphorylated merlin is implicated in the tumorigenesis of sporadic vestibular Schwannomas.
  • Merlin phosphorylation may represent a critical event in Schwannoma progression.
  • Understanding merlin's role could lead to novel therapeutic strategies.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...